Skip to main content
HCPCS Level II/M-Codes/M1390

M1390 HCPCS Level II Code: Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period

M1390 is the authoritative medical code for Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period. This classification is used in medical billing and clinical recording to specify the clinical criteria for patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period (HCPCS Level II M1390), ensuring healthcare documentation aligns with current federal coding standards.

Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.

Medicare Coverage & Payment

  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Service not separately priced (pricing indicator 00)
  • BETOS: Z2
  • Effective: January 1, 2025

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Official Registry Overview & Definition

Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period is a HCPCS Level II code (M1390) for a Medicare-covered supply, service, or procedure. Short description: Pt no doc exm for rec.

Nearest Codes in This Family

Official HCPCS Level II classifications closest to M1390 in its code family, with their registry titles.

  • M1384 — Patients who died during the performance period
  • M1385 — Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up
  • M1386 — Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period
  • M1387 — Patients who died during the performance period
  • M1388 — Patients with documentation of an exam performed for recurrence of melanoma
  • M1391 — All patients who were diagnosed with recurrent melanoma during the current performance period
  • M1392 — Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)
  • M1393 — Patients who were not diagnosed with recurrent melanoma during the current performance period
  • M1394 — Stages i-iii breast cancer
  • M1395 — Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group